Nucleic acid testing (NAT) in high prevalence-low resource settings

Biologicals

Volumn 38, Issue 1, 2010, Pages 59-64

  El Ekiaby, Magdy ^a   Lelie, Nico ^b   Allain, Jean Pierre ^c  

^a Shabrawishi Hospital Blood Bank   (Egypt)

^b Novartis Vaccines and Diagnostics SAS   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY REACTION; ARTICLE; BIOSAFETY; BLOOD DONOR; BLOOD SAFETY; COST EFFECTIVENESS ANALYSIS; DONOR SELECTION; FEASIBILITY STUDY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; NUCLEIC ACID ANALYSIS; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING; TORQUE TENO VIRUS; VIRUS INFECTION;

BLOOD DONORS; BLOOD-BORNE PATHOGENS; DNA, VIRAL; DONOR SELECTION; GENETIC TESTING; HEALTH RESOURCES; HUMANS; MICROBIOLOGICAL TECHNIQUES; NUCLEIC ACIDS; PREVALENCE; RNA, VIRAL; VIRUS DISEASES;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77649336419     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.10.015     Document Type: Article

References (32)

1. Laperche S., Morel P., Deschaseaux M., Bouchardeau F., Alimardani G., Guillaume N., et al. HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation. Transfusion 43 (2003) 1428-1432
2. Postma MJ, Bos JM, van Hulst M. Pharmaco-economics of nucleic-acid amplification testing (NAT) of Dutch blood donors for HIV. International Conference on AIDS, 2002; 14: abstract no. TuPeC4861.
3. Stramer S.L., Glynn S.A., Kleinman S.H., Strong D.M., Caglioti S., Wright D.J., et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. New Engl Med 351 (2004) 760-768
4. van Hulst M, Sagoe KW, Vermande JE, van der Schaaf IP, van der Tuuk Adriani WP. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana). In: Health economics of blood transfusion safety. Rijksuniversiteit Groningen, Netherlands; 2008.
5. Screening Blood Donations for Transfusion-Transmissible Infections. Recommendations. World Health Organization (2009 April) 19-24
6. Behzad-Behbahani A., Mafi-Nejad A., Tabei S.Z., Lankarani K.B., Torab A., and Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Indian J Med Res 123 (2006) 37-42
7. Makroo R.N., Choudhury N., Jagannathan L., Parihar-Malhotra M., Raina V., Chaudhary R.K., et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 127 (2008) 140-147
8. El-Zayadi A.R., Ibrahim E.H., Badran H.M., Saeid A., Moneib N.A., Shemis M.A., et al. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med 18 (2008) 55-61
9. Phikulsod S., Oota S., Tirawatnapong T., Sakuldamrongpanich T., Chalermchan W., Louisirirotchanakul S., et al. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 49 (2009) 1126-1135
10. Li L., Chen P.J., Chen M.H., Chak K.F., Lin K.S., and Tsai S.J. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 48 (2008) 1198-1206
11. Margaritis A.R., Brown S.M., Seed C.R., Kiely P., D'Agostino B., and Keller A.J. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 47 (2007) 1783-1793
12. Wendel S., Levi J.E., Takaoka D.T., Silva I.C., Castro J.P., Torezan-Filho M.A., et al. Primary screening of blood donors by nat testing for HCV-RNA: development of an "in-house" method and results. Rev Inst Med Trop Sao Paulo 49 (2007) 177-185
13. Levi J.E., Wendel S., Takaoka D.T., Silva I.C., Castro J.P., Torezan-Filho M.A., et al. Replacement of HIV p24 Ag test by a multiplex RT-PCR method for primary screening of blood donors. Rev Inst Med Trop Sao Paulo 49 (2007) 171-176
14. Nantachit N., Thaikruea L., Thongsawat S., Leetrakool N., Fongsatikul L., Sompan P., et al. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 47 (2007) 1803-1808
15. Owusu-Ofori S., Temple J., Sarkodie F., Anokwa M., Candotti D., and Allain J.P. Pre-donation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 45 (2005) 133-140
16. van Hulst M., Sagoe K.W., Vermande J.E., and van der Schaaf I.P. van der Tuuk Adriani WP. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana). Value Health 11 (2008) 809-819
17. World Health Organization. The blood cold chain: guide to the selection and procurement of equipment and accessories (2002), World Health Organization, Geneva
18. World Health Organization. Manual on the management, maintenance and use of blood cold chain equipment (2005), World Health Organization, Geneva
19. Jarvis L.M., Dow B.C., Cleland A., Davidson F., Lycett C., Morris K., et al. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sang 89 (2005) 128-134
20. Vermeulen M., Lelie N., Sykes W., Crookes R., Swanevelder J., Gaggia L., et al. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 49 (2009) 1115-1125
21. Chiquete E., Sánchez L.V., Becerra G., Quintero A., Maldonado M., and Panduro A. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center. Ann Hepatol 4 (2005) 275-278
22. El Ekiaby M., Allain J.P., Linnen J., and Lilie N. Hepatitis B virus DNA and surface antigen particles concentrations in Egyptian blood donors; limits of detection of ultra-sensitive nucleic acid screening tests in HBsAg carriers. Vox Sangiunis 172 (2009) A-S04-02
23. El Ekiaby M., Laperche S., Moftah M., Burnouf T., and Lilie N. The impact of different HCV blood screening technologies on the reduction of transfusion transmitted HCV infection risk in Egypt. Vox Sanguinis (2009) 23 2C-S08-03
24. Roth W.K., Weber M., Petersen D., Drosten C., Buhr S., Sireis W., et al. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 42 (2002) 869-875
25. Roth W.K., Weber M., Buhr S., Drosten C., Weichert W., Sireis W., et al. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 42 (2002) 862-868
26. García-Montalvo B.M., Farfán-Ale J.A., Acosta-Viana K.Y., and Puerto-Manzano F.I. Hepatitis B virus DNA in blood donors with anti-HBc as a possible indicator of active hepatitis B virus infection in Yucatan, Mexico. Transfus Med 15 (2005) 371-378
27. El-Zaatari M., Kazma H., Naboulsi-Majzoub M., Haidar M., Ramlawi F., Mahfoud Z., et al. Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications. J Hosp Infect 66 (2007) 278-282
28. Ramia S., Ramlawi F., Kanaan M., Klayme S., and Naman R. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Epidemiol Infect 133 (2005) 695-699
29. Tsatsralt-Od B., Takahashi M., Nishizawa T., Inoue J., Ulaankhuu D., and Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch Virol 150 (2005) 2513-2528
30. Chaudhuri V., Nanu A., Panda S.K., and Chand P. Evaluation of serologic screening of blood donors in India reveals a lack of correlation between anti-HBc titer and PCR-amplified HBV DNA. Transfusion 43 (2003) 1442-1448
31. Bhatti F.A., Ullah Z., Salamat N., Ayub M., and Ghani E. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 47 (2007) 74-79
32. Cunha L., Plouzeau C., Ingrand P., Gudo J.P., Ingrand I., Mondlane J., et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 79 (2007) 1832-1840